Pfizer plans to submit its COVID-19 vaccine approval data to the FDA for emergency use authorization in all school-age children later this month or early October.
CNN reports that the drug company will present studies conducted on children ages five to 11.
Pfizer’s COVID vaccine received emergency use in children 12-15 years of age and is fully approved for persons 16 years of age and older.
Pfizer is also collecting data for its vaccine for babies as young as six months old.
At this time, there is no vaccine available for anyone under the age of 12.
Copyright 2021 by WPLG Local10.com – All rights reserved.